Trackinsight is part of ETF One, the fully integrated ETF platform of Kepler Cheuvreux. Learn more →

Help us improve your experience. Please confirm your investor type:

Global ETF Survey 2026

Trackinsight Global ETF Survey 2026
›ETF Issuers›WisdomTree›WDNA
WDNA

WisdomTree BioRevolution UCITS ETF

Passive ETFEquityESGTheme: BioTech & Genomics

The WDNA Exchange Traded Fund (ETF) is provided by WisdomTree. It is built to track an index: WisdomTree BioRevolution ESG Screened Index. The WDNA ETF provides physical exposure, so by buying it you actually own parts of all the 79 underlying holdings. The dividend policy is capitalization.

Advertisement

$27.60
+$0.75 (+2.78%) yesterday
8:00 AM 10/28/26 Closed
1D price range
$26.76$27.64
52W price range
$17.03$27.86
YTD Perf.
+41.80%
YTD Flows
Annualized volatility
Fund AuM
€38M
Share class AuM
€38M
TTM Yield
-
Tracking Error
Tracking Difference
Characteristics
ISIN
IE000O8KMPM1
TER
0.45%
Inception date
12/3/2021
Issuer
WisdomTree
Benchmark
WisdomTree BioRevolution ESG Screened Index
Replication method
Dividend policy
Capitalization
Compare similar ETFs
ETF Name1w perf.
WDNA
WisdomTree BioRevolution Fund
+2.43%
IBBQ
Invesco Nasdaq Biotechnology ETF
+0.60%
BTEE
iShares Nasdaq US Biotechnology UCITS ETF
+0.59%
203780
Mirae Asset TIGER NASDAQ BIO ETF
+1.58%
TMED
T. Rowe Price Health Care ETF
+1.86%
XHE
State Street SPDR S&P Health Care Equipment ETF
+1.42%
CURE
VanEck Genomics and Healthcare Innovators UCITS ETF
-0.12%
00678
CAPITAL NASDAQ BIOTECHNOLOGY INDEX ETF
-
IBB
iShares Biotechnology ETF
+0.73%
DOCG
L&G Healthcare Technology & Innovation UCITS ETF
+2.54%
HTEC
Robo Global Healthcare Technology and Innovation ETF
+2.52%
PJP
Invesco Dynamic Pharmaceuticals ETF
-0.02%
PBE
Invesco Dynamic Biotechnology & Genome ETF
+1.44%
XHS
State Street SPDR S&P Health Care Services ETF
+0.01%
HELX
Franklin Genomic Advancements ETF
+3.93%
API
PerformanceDec 31, 2025 - Oct 27, 2026
0%10%20%30%40%JANMARMAYJULSEP
Flows
Join for free to unlock
Sector exposures
Data as of 08/31/26
Healthcare
88.35%
Non-Energy Materials
6.36%
Consumer Non-Cyclicals
3.74%
Unavailable
1.55%
Latest WDNA news

No content available for this fund

FAQ about WDNA

WDNA is a passively managed ETF that invests in the Developed Market Blended Cap segment.
WDNA tracks the WisdomTree BioRevolution ESG Screened Net Return Index - USD, through a full replication replication method.
WDNA carries a total expense ratio (TER) of 0.45%.
WDNA was introduced to the market on December 3, 2021.
WisdomTree BioRevolution UCITS ETF, WDNA, is provided by WisdomTree. Learn more about WisdomTree here.
WDNA oversees €38M in assets as of October 27, 2026.
WDNA follows a capitalizing, meaning it reinvests income within the fund.
As of August 31, 2026, WDNA has significant geographic allocations in USA, United Kingdom and Germany.
As of August 31, 2026, WDNA focuses largely on Healthcare, Non-Energy Materials and Consumer Non-Cyclicals.
As of August 31, 2026, WDNA holds 79 positions in its portfolio, with 43.73% of assets concentrated in its top 15 holdings.
As of August 31, 2026, WDNA top three holdings include Moderna, Inc., Twist Bioscience Corp. and Eli Lilly & Co..
The base currency of WDNA is USD.
Top 10 holdings
Data as of 08/31/26
Moderna, Inc.
7.29%
Twist Bioscience Corp.
7.28%
Eli Lilly & Co.
3.57%
Johnson & Johnson
2.77%
Immunome, Inc.
2.61%
10X Genomics, Inc.
2.59%
Natera, Inc.
2.48%
Tempus AI, Inc.
2.24%
United Therapeutics Corp.
2.11%
Darling Ingredients, Inc.
2.02%

Trackinsight
Essentials

A forever free toolbox for fund selection, analysis, research, and ETF portfolio construction.

Essential free account includes:
  • More fund data
  • Compare up to 3 funds
  • More screener filters
  • Edit screener columns from 100+ metrics
  • Watchlists for saving your research
  • Portfolio construction and analysis
  • Personal dashboard for live monitoring
Trackinsight Global ETF Survey 2026: ETFs' Next Act: From Access to Selection. Access the report

Advertisement

Trackinsight

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight
ETF TOOLS
ETF ScreenerCompare ETFsCompare ETF issuersWatchlistsETF Portfolio InsightsIndustry dataETF stock exposure finder
PLATFORM
Support and feedback
ETF NEWS & RESEARCH
Latest ETF NewsETF Research ReportsGlobal ETF Survey 2026Learn ETF investing
PROFESSIONAL SOLUTIONS
Enterprise SolutionsDue Diligence ServicesETF Data Services
SOLUTIONS FOR
Institutional investorsPrivate banksFinancial advisorsFintech and mediaIndividual investors
CONTACT US
General inquiries
Press and media
Advertising opportunities
Support and feedback
© 2014-2026 Trackinsight SA. All rights reserved.
Privacy policy  |  Cookie policy  |    |  Terms of use  |  Imprint
Get our newsletters
Trackinsight